SMCFX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SMCFX Analyst Rating

Moderate Buy

516 Buy

285 Hold

13 Sell

Based on the consensus analyst ratings on 814 stocks held in SMCFX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SMCFX Analyst Price Target

Average Price Target

$75.78

Based on 814 Wall Street analysts offering 12 month price targets to SMALLCAP World Fund, Inc., Class F-2 Shs holdings in the last 3 months. The average price target is $75.78 with a high forecast of $86.33 and a low forecast of $66.02. The average price target represents a 15.71% change from the last price of $65.49.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"64":"$64","87":"$87","69.75":"$69.8","75.5":"$75.5","81.25":"$81.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":86.325,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$86.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":75.776,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$75.78</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":66.017,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$66.02</span>\n  </div></div>","useHTML":true}}],"tickPositions":[64,69.75,75.5,81.25,87],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.72,71.92038461538462,73.12076923076923,74.32115384615385,75.52153846153846,76.72192307692308,77.9223076923077,79.1226923076923,80.32307692307693,81.52346153846153,82.72384615384615,83.92423076923077,85.12461538461538,{"y":86.325,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.72,71.10892307692308,71.49784615384615,71.88676923076923,72.27569230769231,72.66461538461539,73.05353846153847,73.44246153846153,73.83138461538461,74.22030769230768,74.60923076923076,74.99815384615384,75.38707692307692,{"y":75.776,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,70.72,70.35823076923077,69.99646153846153,69.6346923076923,69.27292307692308,68.91115384615384,68.54938461538461,68.18761538461538,67.82584615384616,67.46407692307692,67.10230769230769,66.74053846153846,66.37876923076922,{"y":66.017,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":68.43,"date":1717372800000,"info":"<div>Price: <b>$68<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":67.62,"date":1719792000000,"info":"<div>Price: <b>$68<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":68.73,"date":1722470400000,"info":"<div>Price: <b>$69<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":69.22,"date":1725321600000,"info":"<div>Price: <b>$69<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":71.69,"date":1727740800000,"info":"<div>Price: <b>$72<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":70.3,"date":1730419200000,"info":"<div>Price: <b>$70<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":73.46,"date":1733097600000,"info":"<div>Price: <b>$73<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":69.2,"date":1735776000000,"info":"<div>Price: <b>$69<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":70.24,"date":1738540800000,"info":"<div>Price: <b>$70<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":66.79,"date":1740960000000,"info":"<div>Price: <b>$67<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":65.02,"date":1743465600000,"info":"<div>Price: <b>$65<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":66.25,"date":1746057600000,"info":"<div>Price: <b>$66<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":70.72,"date":1748822400000,"info":"<div>Price: <b>$71<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$86.33

Average Price Target$75.78

Lowest Price Target$66.02

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SMCFX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ARTV

Artiva Biotherapeutics, Inc.

―

5 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ALLO

Allogene Therapeutics

―

11 Buy

2 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GPCR

Structure Therapeutics, Inc. Sponsored ADR

―

10 Buy

0 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

BHVN

Biohaven Ltd.

―

8 Buy

1 Hold

0 Sell

Strong Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PCVX

Vaxcyte, Inc.

―

11 Buy

0 Hold

0 Sell

Strong Buy

―

SMCFX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MAXHEALTH

Max Healthcare Institute Ltd

―

0 Buy

0 Hold

1 Sell

Moderate Sell

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

7476

AS ONE Corporation

―

1 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

MRF

MRF Limited

―

0 Buy

0 Hold

1 Sell

Moderate Sell

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GAW

Games Workshop

―

1 Buy

0 Hold

0 Sell

Moderate Buy

―

xxxxxxxxxxxxxxxxxxxxxxxxxxx

ATE

ALTEN

―

1 Buy

1 Hold

0 Sell

Moderate Buy

―

SMCFX Mutual Fund FAQ

What is SMCFX’s average 12-month price target, according to analysts?

Based on analyst ratings, SMALLCAP World Fund, Inc., Class F-2 Shs’s 12-month average price target is 75.78.

What is SMCFX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for SMCFX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SMCFX a Buy, Sell or Hold?

SMALLCAP World Fund, Inc., Class F-2 Shs has a consensus rating of Moderate Buy which is based on 516 buy ratings, 285 hold ratings and 13 sell ratings.

What is SMALLCAP World Fund, Inc., Class F-2 Shs’s price target?

The average price target for SMALLCAP World Fund, Inc., Class F-2 Shs is 75.78. This is based on 814 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $86.33 ,the lowest forecast is $66.02. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about SMALLCAP World Fund, Inc., Class F-2 Shs?

SMALLCAP World Fund, Inc., Class F-2 Shs’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 814 Wall Streets Analysts.

How can I buy shares of SMCFX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing